Orion Corporation’s partner Bayer submits sNDA to US FDA for oral androgen receptor inhibitor darolutamide: Espoo, Finland Saturday, September 28, 2024, 15:00 Hrs [IST] Finnish ...

The FDA received an application for Nubeqa as a potential treatment option with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer.

BAYRY moves ahead with the submission of an application seeking approval of darolutamide in combination with androgen ...

Dr. Matthew Rutter, a urologist at Graves Gilbert Clinic specializes in prostate cancer. He said that the screening methods have evolved significantly over the years there has been a shift in how ...

Prolonged exposure therapy is a form of psychotherapy for post-traumatic stress disorder or PTSD. After a traumatic event, some people experience unwanted thoughts, disturbing nightmares ...

Traders work on the trading floor at The New York Stock Exchange (NYSE) following the Federal Reserve rate announcement, in New York City, U.S., September 18, 2024. REUTERS/Andrew Kelly/File Photo ...

New York City Mayor Eric Adams on Friday entered the courtroom where he will face federal charges of accepting bribes and illegal campaign contributions from Turkish nationals, as the Democrat ...

The target of the strike in Lebanon was the group’s leader, Hassan Nasrallah, according to Israeli and American officials. The attack came shortly after the Israeli prime minister gave a defiant ...

Oral arguments were heard first thing Thursday morning in Atlanta at the U.S. Court of Appeals for the 11th Circuit. A three-judge panel heard back-to-back oral arguments on behalf of Michael and ...

Sep. 25, 2024 — Exposure to certain pollutants, like fine particles (PM2.5) and nitrogen oxides (NOx), during pregnancy and childhood is associated with differences in the microstructure of the ...

At UN, Erdogan skips mention of Kashmir, a first since 2019 NEW YORK: Turkish President Recep Tayyip Erdogan did not mention Kashmir in his address at the UNGA this year, the first time he has ...